• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

The heiress of $10 billion Perdue Farms and the $12 billion Sheraton Hotels empire wore hand-me-downs, still rides the subway, and flies economy

2

Iran's president admits 'we have many problems' and missiles 'are of no use' as the U.S. chokes its economy while weakening Tehran's grip on Hormuz

3

Six months into the Iran war, the global economy has pulled off a ‘Mission Impossible’ scene, and the Trump family is among the winners

1

The heiress of $10 billion Perdue Farms and the $12 billion Sheraton Hotels empire wore hand-me-downs, still rides the subway, and flies economy

2

Iran's president admits 'we have many problems' and missiles 'are of no use' as the U.S. chokes its economy while weakening Tehran's grip on Hormuz

3

Six months into the Iran war, the global economy has pulled off a ‘Mission Impossible’ scene, and the Trump family is among the winners

Today in the Fortune 500: Agribusiness giant Cargill sells Mosaic, Apple’s stellar holiday sales and American Airlines gets online with Priceline.

By
Shelley DuBois
Shelley DuBois
Down Arrow Button Icon
By
Shelley DuBois
Shelley DuBois
Down Arrow Button Icon
January 19, 2011, 12:53 PM ET
Add Fortune on Google for similar content.
American Airlines Boeing 757 on final approach...
Image via Wikipedia

The Fortune 500 comes out just once a year, but the companies on it make headlines every day. Here then are today’s highlights of news and happenings coming from the biggest names in business.

By Shelley DuBois, reporter

CARGILL’S LATEST MOVE TO STAY PRIVATE involves selling $24.3 billion worth of shares in fertilizer company Mosaic (MOS). Mosaic, which has a market cap of $38 billion, could now be up for a takeover by a foreign agribusiness company. The sale will allow Cargill to stay private and still placate representatives of charitable trusts formerly held by the late Margaret Cargill, the granddaughter of the company’s founder, by letting them cash in on Mosaic shares. The deal should also help Cargill pay off some debt. [Wall Street Journal]

APPLE STILL ‘FIRING ON ALL CYLINDERS,’ the company’s CEO Steve Jobs said in a news release about Apple’s great sales numbers from the holiday quarter. Apple’s (APPL) net income in the last three months jumped to $6 billion–that’s a 78% increase from the same time the previous year. The good sales numbers should help assuage fears from investors spooked by recent news that Jobs will be taking medical leave. [New York Time]

OUT OF ORBITZ, ONTO PRICELINE American Airlines announced that it will soon team up with travel site Priceline.com. The announcement comes as American Airlines (AMR) has had a number of spats with other search sites. Travelocity.com and Expedia.com, for example, both dropped data for American Airlines flights, because they refused to use the airline’s own online ticket sales platform, called “Direct Connect.” Priceline.com, however, has agreed to work with the technology. [CNNMoney]

DELTA STOCK RUNS OUT OF GAS Delta stock fell the farthest for the company since October 2009, dropping 8.2% to $11.70 on Tuesday. Delta (DAL) was hit hard by increased fuel prices, and the company claims that the high cost of fuel will remain its greatest challenge going forward. [Bloomberg Businessweek]

SO LONG, LONG JOHN’S Yum Brands announced plans to sell the seafood chain Long John Silvers along with its A&W All-American Food restaurants because they no longer fit into the food company’s corporate strategy. Instead, Yum (YUM) Brands, which owns 37,000 stores worldwide, wants to focus on strengthening its top-selling brands abroad. Namely, Yum wants to make sure that KFC, Taco Bell and Pizza Hut access more of the markets in China, India, South Africa and Russia. [Wall Street Journal]

JOHNSON & JOHNSON PARTNERS TO SPEED ALZHEIMER’S DRUG DEVELOPMENT The drug development arm of Johnson & Johnson (JNJ) has teamed up with an medical research facility called the Sanford-Burnham Institute in the hopes that the partnership will  shorten the path to getting new Alzheimer’s treatments FDA approval. This kind of academic-industry partnership is becoming a trend, as companies look for ways to move quickly through early-stage research. [FierceBiotech]

About the Author
By Shelley DuBois
See full bioRight Arrow Button Icon
Add Fortune on Google for similar content.

Latest in


Most Popular

Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • TikTok icon
  • YouTube icon

    Latest in


    Most Popular

    © 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
    FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.